Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 8, 2025

Study Completion Date

May 8, 2025

Conditions
Breast Cancer
Interventions
DEVICE

Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort

Participants will have up to 9 DOSI scans at 6 different time points during the course of their neoadjuvant chemotherapy. The time course of chemotherapy may vary between 3-9 months depending on the type chemotherapy subjects receive. Depending on chemotherapy schedule, subjects may or may not be asked to participate in all the 6 measurement time points. The number of DOSI scans each subject requires will be decided during consent. Each DOSI scan will take about 30-60 minutes, although scans at infusion time point will take longer in total due to repeated or continuous measurements.

DEVICE

Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort

Participants will have 1 DOSI scan at baseline. The DOSI scan will take about 30-60 minutes.

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

Boston Medical Center

OTHER